Nature of Operations, Corporate History, and Going Concern and Management Plans - Additional Information (Detail) $ / shares in Units, $ in Thousands				9 Months Ended	12 Months Ended
	Apr. 02, 2024 USD ($) Patients $ / shares	Jun. 28, 2023 USD ($)	Aug. 02, 2022 USD ($) shares	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) $ / shares
Net Income (Loss)					$ (8,320)	$ (14,649)
Negative cash flow from operations					(7,176)	(11,865)
Cash and cash equivalents				$ 4,909	4,909	1,535
Accumulated deficit				$ (159,876)	$ (159,876)	$ (151,375)
Stock issued during period shares new issues | shares			662,000
Net proceeds available under the stock purchase agreement			$ 2,008
Proceeds from grant funding		$ 2,000
Description of grant funding received					In addition, on June 28, 2023, the Company announced that it had been awarded approximately $2,000 in grant funding to be received over a two-year period for its REM-001 project.
Substantial Doubt about Companys Ability to Continue Going Concern Period					1 year
Common stock, par value | $ / shares				$ 0.001	$ 0.001	$ 0.001
Minimum of number of patients enrolled | Patients	10
Termination fees payable	$ 1,000
Tu H U R A Biosciences, Inc. [Member]
Description of contingent value rights					Existing Company stockholders will receive contingent value rights (“CVR”), entitling them to receive shares of the Company's common stock upon achievement of enrollment of a minimum of 10 patients in the REM-001 clinical trial, with such patients each completing 8 weeks of follow-up on or before December 31, 2025.
Tuhura [Member]
Common stock, par value | $ / shares	$ 0.001
Termination fees payable	$ 1,000
Tuhura [Member] | Contingent Value Rights [Member] | Maximum [Member]
Equity method investment, ownership percentage	94.55%
Tuhura [Member] | Contingent Value Rights [Member] | Minimum [Member]
Equity method investment, ownership percentage	97.15%
Merger Agreement [Member]
Reimbursement of expenses	$ 750
Merger Agreement [Member] | Contingent Value Rights [Member] | Maximum [Member]
Equity method investment, ownership percentage	5.45%
Merger Agreement [Member] | Contingent Value Rights [Member] | Minimum [Member]
Equity method investment, ownership percentage	2.85%
Merger Agreement [Member] | Tuhura [Member]
Reimbursement of expenses	$ 750
Lincoln Park Purchase Agreement [Member]
Number of shares issued in transaction | shares					400,000
Sale of stock, consideration received on transaction					$ 105
At The Market Facility [Member]
Number of shares issued in transaction | shares				53,151,000	53,151,000
Sale of stock, consideration received on transaction				$ 10,471	$ 10,471